Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
26.11
-2.85 (-9.84%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,025,274
Profits / Employee
-$575
Market Cap
531.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| OmniAb | 89 |
| AgomAb Therapeutics NV | 62 |
| Tectonic Therapeutic | 60 |
| Oculis Holding AG | 60 |
| Altimmune | 57 |
ASMB News
- 5 days ago - Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference - GlobeNewsWire
- 7 days ago - Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - GlobeNewsWire
- 14 days ago - Assembly Biosciences price target raised to $53 from $45 at Mizuho - TheFly
- 14 days ago - Assembly Biosciences initiated with a Buy at UBS - TheFly
- 4 weeks ago - Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TheFly
- 4 weeks ago - Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - GlobeNewsWire
- 4 weeks ago - Assembly Biosciences Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Assembly Biosciences Earnings release: Q2 2026 - Filings